Jennifer Doudna co-invented a groundbreaking new technology for editing genes known as CRISPR-Cas9. This tool allows scientists to make precise edits to DNA strands, which could lead to treatments for genetic diseases but could also be used to create “engineered” humans. Professor Doudna will review how CRISPR-Cas9 works and the potential it holds for treating disease. She will also discuss the bioethics of this new tool.
Dr. Jennifer Doudna is a member of the departments of Molecular and Cell Biology and Chemistry at UC Berkeley, the Howard Hughes Medical Institute, and Lawrence Berkeley National Lab, along with the National Academy of Sciences, and the American Academy of Arts and Sciences.